SCHEMBL31681318

SCHEMBL31681318

Cc1cccc(NS(=O)(=O)c2ccc(C(N)=O)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.70
▸ LIMK1 P53667 1/20 0.60
▸ LIMK2 P53671 1/20 0.60
▸ ATIC P31939 1/20 0.59
▸ TCF4 P15884 1/20 0.58
▸ CTNNB1 P35222 1/20 0.58
▸ ALDH1A1 P00352 4/20 0.57
▸ MAPT P10636 2/20 0.57
▸ HPGD P15428 1/20 0.57
▸ MEN1 O00255 2/20 0.55
▸ KMT2A Q03164 2/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ XBP1 P17861 1/20 0.55
▸ BRD4 O60885 1/20 0.55
▸ GAA P10253 1/20 0.53
▸ HDAC4 P56524 1/20 0.53
▸ HDAC1 Q13547 1/20 0.53
▸ HDAC6 Q9UBN7 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL662338 0.87 KMT2A (0.65) MAPK1LIMK1LIMK2TCF4CTNNB1
SCHEMBL4928453 0.86 TCF4 (0.73) MAPK1ATICTCF4CTNNB1ALDH1A1
SCHEMBL31681206 0.84 TCF4 (0.76) MAPK1LIMK1LIMK2TCF4CTNNB1
SCHEMBL3701951 0.83 CA12 (0.71) MAPK1TCF4CTNNB1ALDH1A1MAPT
SCHEMBL5445300 0.82 LMNA (0.66) LIMK2ATICTCF4CTNNB1ALDH1A1
SCHEMBL4573407 0.82 HPGD (0.74) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL6318007 0.82 HPGD (0.74) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL1592806 0.82 LMNA (0.60) MAPK1LIMK1LIMK2TCF4CTNNB1
SCHEMBL2240551 0.82 HTR6 (0.73) MAPK1ALDH1A1MAPTMEN1KMT2A
SCHEMBL5452240 0.82 TMPRSS6 (0.73) ATICALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275539-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2025-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275539-A1 APYRASE INHIBITORS APEH, GBA3, PON1 MAPK1 2652/4885LIMK1 4374/4885LIMK2 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback